MyFinsight
Home
Blog
About
NEUROCRINE BIOSCIENCES INC (NBIX)
NEUROCRINE BIOSCIENCES INC (NBIX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$128,600K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Sales and maturities of availabl...
Proceeds from borrowings under r...
Net income
Others
Negative Cash Flow Breakdown
Acquisition of business, net of ...
Repayments of borrowings under r...
Accounts receivable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
144,400
197,900
153,700
209,500
Stock-based compensation
65,000
57,200
58,600
53,700
Charges associated with convertible senior notes
-
-
0
0
Impairment charges associated with leased properties
-
-
0
700
Depreciation
8,400
7,200
6,400
6,700
Amortization of inventory fair-value step-up
3,000
-
-
-
Accretion of discount on available-for-sale debt securities, net
300
1,300
2,000
2,700
Realized loss on sale of available-for-sale debt securities
-5,200
-
-
-
Amortization of acquired intangible assets
16,400
100
1,100
1,000
Changes in fair values of equity investments
1,200
25,300
2,700
30,600
Deferred income taxes
-25,300
-61,100
48,200
168,300
Non-cash lease expense
900
2,700
5,900
20,900
Gain on sale of business, net of transaction costs
0
28,600
-
-
Other
0
0
0
200
Accounts receivable
84,300
81,400
-38,400
132,300
Inventory
6,500
-4,300
3,400
12,300
Accounts payable and accrued liabilities
-8,500
-14,300
76,500
55,800
Income tax assets and liabilities
-59,600
119,800
35,500
-54,300
Other assets and liabilities, net
-78,800
31,400
27,800
42,100
Cash flows from operating activities
136,400
145,800
388,400
227,500
Purchases of available-for-sale debt securities
37,400
819,500
323,000
408,500
Sales and maturities of available-for-sale debt securities
2,268,300
259,200
267,700
225,000
Acquisition of business, net of cash acquired
2,358,500
-
-
-
Purchases of equity investments
-
-
0
-
Proceeds from sale of business
0
63,200
-
-
Capital expenditures
7,800
9,100
-2,400
13,200
Cash flows from investing activities
-135,400
-506,200
-52,900
-196,700
Proceeds from borrowings under revolving credit facility
600,000
-
-
-
Repayments of borrowings under revolving credit facility
600,000
-
-
-
Payment of debt issuance costs
6,700
-
-
-
Issuances of common stock under benefit plans
84,800
23,600
37,300
45,600
Taxes paid related to net share settlement of equity awards
2,700
55,700
-
-
Repurchases of common stock
12,000
54,000
0
0
Payments to settle convertible senior notes
-
-
0
0
Cash flows from financing activities
63,400
-86,100
37,300
45,600
Effect of exchange rate changes on cash and cash equivalents
0
-
0
-200
Change in cash, cash equivalents and restricted cash
64,400
-446,500
372,800
76,200
Cash, cash equivalents and restricted cash at beginning of period
274,500
721,000
348,200
241,000
Cash, cash equivalents and restricted cash at end of period
338,900
274,500
721,000
348,200
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$144,400K
(25.13%↑ Y/Y)
Proceeds from borrowings
under revolving...
$600,000K
Other assets and
liabilities, net
-$78,800K
(-209.02%↓ Y/Y)
Stock-based compensation
$65,000K
(-38.45%↓ Y/Y)
Amortization of acquired
intangible assets
$16,400K
(720.00%↑ Y/Y)
Depreciation
$8,400K
(-34.88%↓ Y/Y)
Realized loss on sale of
available-for-sale debt securities
-$5,200K
Amortization of inventory
fair-value step-up
$3,000K
Non-cash lease expense
$900K
(-93.71%↓ Y/Y)
Issuances of common stock
under benefit plans
$84,800K
(82.37%↑ Y/Y)
Cash flows from
operating activities
$136,400K
(-18.23%↓ Y/Y)
Cash flows from
financing activities
$63,400K
(152.31%↑ Y/Y)
Canceled cashflow
$185,700K
Canceled cashflow
$621,400K
Change in cash, cash
equivalents and restricted...
$64,400K
(107.74%↑ Y/Y)
Canceled cashflow
$135,400K
Accounts receivable
$84,300K
(-27.70%↓ Y/Y)
Income tax assets and
liabilities
-$59,600K
Deferred income taxes
-$25,300K
(50.49%↑ Y/Y)
Accounts payable and
accrued liabilities
-$8,500K
(-130.47%↓ Y/Y)
Inventory
$6,500K
(1725.00%↑ Y/Y)
Changes in fair values of
equity investments
$1,200K
(103.22%↑ Y/Y)
Accretion of discount on
available-for-sale debt...
$300K
(-96.25%↓ Y/Y)
Sales and maturities
of...
$2,268,300K
(280.14%↑ Y/Y)
Repayments of borrowings
under revolving...
$600,000K
Repurchases of common stock
$12,000K
(-92.84%↓ Y/Y)
Payment of debt issuance
costs
$6,700K
Taxes paid related to
net share...
$2,700K
Cash flows from
investing activities
-$135,400K
(-814.86%↓ Y/Y)
Canceled cashflow
$2,268,300K
Acquisition of business, net
of cash acquired
$2,358,500K
Purchases of
available-for-sale debt securities
$37,400K
(-93.64%↓ Y/Y)
Capital expenditures
$7,800K
(-66.38%↓ Y/Y)
Buy us a coffee